Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$633,388
-$100,768 QoQ
Shares Held
76,220
+10.0% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#72
of 201 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANGROVE PARTNERS IM, LLC holds $8,126,934 across 17 Biotechnology names. ARVN ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
9,916 | $1,160,866 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
47,927 | $1,064,458 | |
| 3 | ALT |
Altimmune, Inc.
|
239,280 | $727,411 | |
| 4 | 33,346 | $708,602 | |||
| 5 | ARVN |
Arvinas, Inc.
This page
|
76,220 | $633,388 | |
| 6 | LENZ |
LENZ Therapeutics, Inc.
|
96,749 | $549,534 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
34,140 | $503,906 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
71,705 | $496,198 |
All Filings in ARVN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $633,388 | 76,220 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $734,156 | 69,260 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||